期刊文献+

原发性失眠患者的血清P物质水平及其影响因素 被引量:8

Serum level of substance P and related factors in patients with primary insomnia
下载PDF
导出
摘要 目的探讨原发性失眠患者血清P物质(substance P,SP)水平及其影响因素。方法收集原发性失眠患者46例(患者组)及睡眠正常的健康对照42例(对照组),采用匹兹堡睡眠质量指数问卷(Pittsburgh Sleep Quality Index,PSQI)、状态特质焦虑问卷(State-Trait Anxiety Inventory,STAI)和贝克抑郁问卷(Beck Depression Inventory,BDI)评定受试者的主观睡眠状况及焦虑、抑郁水平,以酶联免疫吸附法对受试者血清SP含量进行测定。采用独立样本t检验比较两组血清SP水平,并采用线性回归分析所有受试者血清SP水平的影响因素。结果患者组血清SP水平高于对照组([6.68±3.10)ng/mL vs(.5.27±2.49)ng/mL],差异有统计学意义(P<0.05)。单因素线性回归分析中,血清SP与PSQI总分(β=0.143,P<0.05)、BDI总分(β=0.116,P<0.05)分别呈正关联;与性别、年龄、体重指数、病程及SAI、TAI总分无统计学相关性(均P>0.05)。多因素回归分析显示,仅PSQI总分为血清SP水平的影响因素(β=0.143,P<0.05)。结论原发性失眠患者存在外周血SP水平紊乱,SP可能参与了原发性失眠的发病机制。 Objective To explore the serum level of substance P (SP) in patients with primary insomnia and its related factors. Methods A total of 46 patients with primary insomnia and 42 healthy controls with normal sleep were enrolled in our study. The Pittsburgh Sleep Quality Index (PSQI), State-Trait Anxiety Inventory (STAI), and Beck Depression Inventory (BDI) were used to assess the subjective sleep quality and the levels of anxiety and depression. The serum SP concentrations of all subjects were determined by enzyme-linked immuno sorbent assay. Student' s t-test was used to compare the SP levels between two groups; linear regression was used to analyze the affecting factors of all subjects' SP level. Results The serum SP levels in patients were significantly higher than those in controls [(6.68±3.10) ng/mL vs. (5.27±2.49) ng/mL, P〈0.05]. In simple linear regression, scores of PSQI (β= 0.143, P〈0.05) and BDI (β=0.116, P〈0.05) were significantly and positively correlated with the serum SP levels respectively in all subjects, while gender, age, body mass index, course of insomnia and the scores of SAI and TAI were not significantly correlated with the serum SP levels in all subjects (P〉0.05). Multiple linear regression analysis showed that only score of PSQI significantly affected individuals' serum SP level (β=0.143, P〈0.05). Conclusion The results suggest that there is a disturbance of serum SP level in patients with primary insomnia. SP may involve in the pathophysiological progress of primary insomnia.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2013年第2期65-69,共5页 Chinese Journal of Nervous and Mental Diseases
关键词 原发性失眠症 P物质 睡眠质量 Primary insomnia Substance P Sleep quality
  • 相关文献

参考文献17

  • 1Monti JM. The structure of the dorsal raphe nucleus and its rele-vance to the regulation of sleep and wakefulness[J]. Sleep MedRev, 2010, 14(5):307-317. 被引量:1
  • 2司天梅,舒良,党卫民,苏允爱,陈景旭,董问天,孔庆梅,张卫华.简明国际神经精神访谈中文版的临床信效度[J].中国心理卫生杂志,2009,23(7):493-497. 被引量:228
  • 3汪向东,王希林,马弘.心理卫生评定量表手册增订版[M].北京:中国心理卫生杂志社,1999:235~237. 被引量:296
  • 4Shekleton JA, Rogers NL, Rajaratnam SMW. Searching for thedaytime impairments of primary insomnia[J]. Sleep Med Rev,2010, 14(1):47-60. 被引量:1
  • 5Ozminkowski RJ, Wang S, Walsh JK. The direct and indirectcosts of untreated insomnia in adults in the United States[J].Sleep, 2007, 30(3):263-273. 被引量:1
  • 6Daley M, Morin CM, LeBlanc M, et al. The economic burden ofinsomnia: direct and indirect costs for individuals with insomniasyndrome, insomnia symptoms, and good sleepers[J]. Sleep,2009, 32(1):55-64. 被引量:1
  • 7Rocha FL, Hara C, Rorigues CV, et al. Is insomnia a marker forpsychiatric disorders in general hospitals?[J]. Sleep Med, 2005,6(6):549-553. 被引量:1
  • 8Taylor DJ, Mallory U, Lichstein KL, et al. Comorbidity of chron-ic insomnia with medical problems[J]. Sleep, 2007,30(2):213-218. 被引量:1
  • 9Ndersen ML, Nascimento DC, Machado RB, et al. Sleep distur-bance induced by substance P in mice[J]. Behav Brain Res,2006,167(2):212-218. 被引量:1
  • 10Lieb K, Ahlvers K, Dancker K, et al. Effects of the neuropep-tide substance P on sleep, mood and neuroendocrine measuresin healthy young men[J]. Neuropsychopharmacol, 2002, 27(6):1041-1049. 被引量:1

二级参考文献54

  • 1Morales-Medina JC,Dumont Y,Quirion R.A possible role of neuropeptide Y in depression and stress[J].Brain Res,2010,1314(C):194-205. 被引量:1
  • 2Heilig M,Zachrisson O,Thorsell A,et al.Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression:preliminary evidence for association with preproNPY gene polymorphism[J].J Psychiatric Res,2004,38(2):113-121. 被引量:1
  • 3Bondy B,Baghai TC,Minov C,et al.Substance P serum levels are increased in major depression:preliminary results[J].Biol Psychiatry,2003,53(6):538-542. 被引量:1
  • 4Geracioti TD Jr,Carpenter LL,Owens,MJ,et al.Elevated cerebrospinal fluid substance P concentrations in post-traumatic stress disorder and major depression[J].Am J Psychiatry,2006,163(4):637-643. 被引量:1
  • 5Nikisch G,Agren H,Eap CB,et al.Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram[J].Int J Neuropsychopharmacol,2005,8(3):403-410. 被引量:1
  • 6Nikisch G,Mathe AA.CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy[J].Eur Psychiatry,2008,23(5):356-359. 被引量:1
  • 7Kuromitsu J,Yokoi A,Kawai T,et al.Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder[J].Brain Res Gene Expr Patterns,2001,1(1):17-21. 被引量:1
  • 8Caberlotto L,Hurd YL.Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects.Relationship of Y(2) subtype to suicidal behavior[J].Neuropsychopharmacology,2001,25(1):91-97. 被引量:1
  • 9Mantyh PW.Neurobiology of substance P and the NK1 receptor[J].J clin Psychiatry,2002,63(Supp l 11):6-10. 被引量:1
  • 10Lieb K,Ahlvers K,Dancker K,et al.Effects of the neuropeptides substance P on sleep,mood,and neuroendocrine measures in healthy young men[J].Neurop sychopharmacology,2002,27 (6):1041-1049. 被引量:1

共引文献550

同被引文献92

引证文献8

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部